TAM
ADPT icon

Tiverton Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Tiverton Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$139K Buy
+4,498
New +$184K ﹤0.01% 600

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tiverton Asset Management's ADPT Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2019: 4,498 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #600 among its holdings.

117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

  • Tiverton Asset Management held 4,498 shares of Adaptive Biotechnologies worth $139K as of Q3 2019.
  • Adaptive Biotechnologies was a new Tiverton Asset Management position in Q3 2019.
  • Adaptive Biotechnologies made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #600 holding.
  • 117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.